29 Sep 2014 07:00
29 September 2014
Avacta Group plc
("Avacta" or the "Group")
Investor Results Briefing
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces it will be hosting an investor results presentation on Thursday 16 October 2014 where Alastair Smith, CEO, Craig Slater, COO and Tim Sykes, CFO will present the Company's results for its financial year ended 31 July 2014.
The investor event, open to all investors, will be held from 16:30 at the Black Bar, Rocket, 6 Adams Court, EC2N 1DX followed by drinks and canapés.
For more information or to register to attend, contact Walbrook PR (contact details are below).
Enquiries:
Avacta Group plc Alastair Smith, Chief Executive Officer Tim Sykes, Chief Financial Officer | Tel: +44 (0) 844 414 0452 www.avacta.com |
Numis Securities Limited Michael Meade / Freddie Barnfield - Nominated Adviser James Black - Corporate Broking | Tel: +44 (0) 207 260 1000 www.numiscorp.com |
Media Enquiries Walbrook PR Ltd Anna Dunphy / Mike Wort | Tel: +44 (0) 207 933 8780 avacta@walbrookpr.com
|
About Avacta Group plc - www.avacta.com
Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
Avacta Analytical www.avactaanalytical.com
| High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development. |
Avacta Animal Health www.avactaanimalhealth.com
| Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod. |
Avacta Life Sciences www.avactalifesciences.com
| Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development. |
Avacta Group (AVCT)